Christine M. Pak

ORCID: 0009-0009-2321-1605
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Primary Care and Health Outcomes
  • Cancer-related gene regulation
  • Genomic variations and chromosomal abnormalities
  • Nail Diseases and Treatments
  • Hemophilia Treatment and Research
  • Cutaneous lymphoproliferative disorders research
  • Health Sciences Research and Education
  • Fungal Infections and Studies
  • Health Policy Implementation Science
  • Cancer Genomics and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
  • Hemoglobinopathies and Related Disorders
  • Biomedical Text Mining and Ontologies

Kaiser Permanente Center for Health Research
2022-2024

University of Illinois Chicago
2023

Oregon Health & Science University
2016-2018

Synthesis and curation of evidence regarding the clinical actionability secondary findings (SFs) from genome-scale sequencing are needed to support decision-making on reporting these findings. To assess SFs in children adolescents, Clinical Genome Resource established Pediatric Actionability Working Group (AWG).The AWG modified framework existing Adult AWG, which included production summary reports for genes associated conditions consensus scores specific outcome-intervention pairs....

10.1016/j.gim.2022.02.019 article EN cc-by-nc-nd Genetics in Medicine 2022-03-25
Coming Soon ...